Abstract:Influenza A virus (IAV) H1N1 infection is a constant threat to human health and it remains so due to the lack of an effective treatment. Since melatonin is a potent antioxidant and anti-inflammatory molecule with anti-viral action, in the present study we used melatonin to protect against H1N1 infection under in vitro and in vivo conditions. The death rate of the H1N1-infected mice was negatively associated with the nose and lung tissue local melatonin levels but not with serum melatonin concentrations. The H1N1-infected AANAT -/- melatonin-deficient mice had a significantly higher death rate than that of the WT mice and melatonin administration significantly reduced the death rate. All evidence confirmed the protective effects of melatonin against H1N1 infection. Further study identified that the mast cells were the primary targets of melatonin action, i.e., melatonin suppresses the mast cell activation caused by H1N1 infection. The molecular mechanisms involved melatonin down-regulation of gene expression for the HIF-1 pathway and inhibition of proinflammatory cytokine release from mast cells; this resulted in a reduction in the migration and activation of the macrophages and neutrophils in the lung tissue. This pathway was mediated by melatonin receptor 2 (MT2) since the MT2 specific antagonist 4P-PDOT significantly blocked the effects of melatonin on mast cell activation. Via targeting mast cells, melatonin suppressed apoptosis of alveolar epithelial cells and the lung injury caused by H1N1 infection. The findings provide a novel mechanism to protect against the H1N1-induced pulmonary injury, which may better facilitate the progress of new strategies to fight H1N1 infection or other IAV viral infections. IAV is one of the most common respiratory pathogens, leading to acute lung injury and a high morbidity rate. Melatonin has important regulatory roles in modulating immune responses during acute inflammatory conditions. It is of great significance to explore the protection effect of melatonin against the H1N1-induced pulmonary injury. Here, we found that melatonin had essential impacts on protection against IAV infection in mice. For the first time, we proved that melatonin had the capacity to suppress the activation of mast cells and the associated inflammatory response during H1N1 infection. The molecular mechanisms involved melatonin down-regulation of gene expression for the HIF-1 pathway mediated by MT2 and inhibition of proinflammatory cytokine release from mast cells, ultimately, leading to a reduction in the migration and activation of the macrophages and neutrophils in the lung tissue. Consequently, melatonin suppressed apoptosis of alveolar epithelial cells and the lung injury caused by H1N1 infection. Our findings highlight a novel mechanism to protect against the H1N1-induced pulmonary injury, and also provide insights into the new strategies to fight IAV infections.

Response of Human Retinal Microvascular Endothelial Cells to Influenza A (H1N1) Infection and the Underlying Molecular Mechanism

Dynamic Variations in the Peripheral Blood Lymphocyte Subgroups of Patients with 2009 Pandemic H1N1 Swine-Origin Influenza A Virus Infection

HA of H1N1 enhanced the expression of ICAM-1 and IL-6 in HUVECs and pathological injury in the lungs in mice

Changes in peripheral immunocytes and cytokines in patients with HIN1 influenza A virus infection

Differential Transcriptional Responses in Corneal and Lung Epithelial Cells to Seasonal Influenza with Potential Function of LGALS9

Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study

The effect of influenza A (H1N1) pdm09 virus infection on cytokine production and gene expression in BV2 microglial cells

Bioinformatic analysis of PD 1 checkpoint blockade responsive immune microenvironment in severe influenza infection

Inhibitory Effects and Related Molecular Mechanisms of Huanglian-Ganjiang Combination Against H1N1 Influenza Virus

Integrated Analysis of Human Influenza A (H1N1) Virus Infectionrelated Genes to Construct a Suitable Diagnostic Model

Evaluation of Ocular Symptoms and Tropism of SARS‐CoV‐2 in Patients Confirmed with COVID‐19

Transcriptomic Profiling of Mouse Mast Cells upon Pathogenic Avian H5N1 and Pandemic H1N1 Influenza a Virus Infection

Melatonin alleviates lung injury in H1N1-infected mice by mast cell inactivation and cytokine storm suppression

Inhibition of pre-B cell colony-enhancing factor attenuates inflammation and apoptosis induced by pandemic H1N1 2009 in lung endothelium.

Proteomic Analysis at the Subcellular Level for Host Targets Against Influenza A Virus (H1N1)

The Identification Distinct Antiviral Factors Regulated Influenza Pandemic H1N1 Infection

Molecular Consequences of Peripheral Influenza A Infection on Cell Populations in the Murine Hypothalamus

Down-regulation of Mir-155 Inhibits Inflammatory Response in Human Pulmonary Microvascular Endothelial Cells Infected with Influenza A Virus by Targeting Sphingosine-1-phosphate Receptor 1

IL-17 response mediates acute lung injury induced by the 2009 Pandemic Influenza A (H1N1) Virus

Two cases of exudative retina detachment and uveitis following H1N1 influenza vaccination.

IL-15 induced bystander activation of CD8+ T cells may mediate endothelium injury through NKG2D in Hantaan virus infection